LANSDOWNE BIOTECHNICS LIMITED


Silverfin false 30/09/2021 30/09/2021 11/09/2020 Mr D C Lansdowne 11/09/2020 11 May 2022 The principal activity of the Company during the financial period was scientific development and research. 12873625 2021-09-30 12873625 bus:Director1 2021-09-30 12873625 core:CurrentFinancialInstruments 2021-09-30 12873625 core:ShareCapital 2021-09-30 12873625 core:RetainedEarningsAccumulatedLosses 2021-09-30 12873625 core:ComputerEquipment 2020-09-10 12873625 2020-09-10 12873625 core:ComputerEquipment 2021-09-30 12873625 bus:OrdinaryShareClass1 2021-09-30 12873625 2020-09-11 2021-09-30 12873625 bus:FullAccounts 2020-09-11 2021-09-30 12873625 bus:SmallEntities 2020-09-11 2021-09-30 12873625 bus:AuditExemptWithAccountantsReport 2020-09-11 2021-09-30 12873625 bus:PrivateLimitedCompanyLtd 2020-09-11 2021-09-30 12873625 bus:Director1 2020-09-11 2021-09-30 12873625 core:ComputerEquipment 2020-09-11 2021-09-30 12873625 bus:OrdinaryShareClass1 2020-09-11 2021-09-30 iso4217:GBP xbrli:pure xbrli:shares

Company No: 12873625 (England and Wales)

LANSDOWNE BIOTECHNICS LIMITED

Unaudited Financial Statements
For the financial period from 11 September 2020 to 30 September 2021
Pages for filing with the registrar

LANSDOWNE BIOTECHNICS LIMITED

Unaudited Financial Statements

For the financial period from 11 September 2020 to 30 September 2021

Contents

LANSDOWNE BIOTECHNICS LIMITED

STATEMENT OF FINANCIAL POSITION

As at 30 September 2021
LANSDOWNE BIOTECHNICS LIMITED

STATEMENT OF FINANCIAL POSITION (continued)

As at 30 September 2021
Note 30.09.2021
£
Fixed assets
Tangible assets 3 2,390
2,390
Current assets
Debtors 4 58,665
Cash at bank and in hand 1,339
60,004
Creditors
Amounts falling due within one year 5 ( 32,722)
Net current assets 27,282
Total assets less current liabilities 29,672
Provisions for liabilities ( 454)
Net assets 29,218
Capital and reserves
Called-up share capital 6 1
Profit and loss account 29,217
Total shareholder's funds 29,218

For the financial period ending 30 September 2021 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

  • The member has not required the Company to obtain an audit of its financial statements for the financial period in accordance with section 476;
  • The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements; and
  • These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime and a copy of the Profit and Loss Account has not been delivered.

The financial statements of Lansdowne Biotechnics Limited (registered number: 12873625) were approved and authorised for issue by the Director on 11 May 2022. They were signed on its behalf by:

Mr D C Lansdowne
Director
LANSDOWNE BIOTECHNICS LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial period from 11 September 2020 to 30 September 2021
LANSDOWNE BIOTECHNICS LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial period from 11 September 2020 to 30 September 2021
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial period, unless otherwise stated.

General information and basis of accounting

Lansdowne Biotechnics Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is C/O Bishop Fleming, Chy Nyverow, Newham Road, Truro, TR1 2DP, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the company and rounded to the nearest £.

Going concern

The director has assessed the Statement of Financial Position and likely future cash flows at the date of approving these financial statements. The director has a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Statement of Financial Position date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible fixed assets

Tangible fixed assets are stated at cost (or deemed cost) or valuation less accumulated depreciation and accumulated impairment losses. Cost includes costs directly attributable to making the asset capable of operating as intended. Depreciation is provided on all tangible fixed assets, other than investment properties and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset over its expected useful life, as follows:

Computer equipment 20 % reducing balance

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Statement of Financial Position date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Income and Retained Earnings as described below.

Non-financial assets
At each balance sheet date, the company reviews its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted. Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Provisions

Provisions are recognised when the Company has a present obligation (legal or constructive) as a result of a past event, it is probable that the Company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.

The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the Statement of Financial Position date, taking into account the risks and uncertainties surrounding the obligation. Where a provision is measured using the cash flows estimated to settle the present obligation, its carrying amount is the present value of those cash flows (when the effect of the time value of money is material).

When some or all of the economic benefits required to settle a provision are expected to be recovered from a third party, a receivable is recognised as an asset if it is virtually certain that reimbursement will be received and the amount of the receivable can be measured reliably.

Ordinary share capital

The ordinary share capital of the Company is presented as equity.

2. Employees

Period from
11.09.2020 to
30.09.2021
Number
Monthly average number of persons employed by the Company during the period, including the director 3

3. Tangible assets

Computer equipment Total
£ £
Cost
At 11 September 2020 0 0
Additions 2,516 2,516
At 30 September 2021 2,516 2,516
Accumulated depreciation
At 11 September 2020 0 0
Charge for the financial period 126 126
At 30 September 2021 126 126
Net book value
At 30 September 2021 2,390 2,390

4. Debtors

30.09.2021
£
Trade debtors 48,498
Prepayments and accrued income 10,167
58,665

5. Creditors: amounts falling due within one year

30.09.2021
£
Trade creditors 120
Amounts owed to director 4,000
Accruals 13,118
Corporation tax 6,222
Other taxation and social security 9,262
32,722

6. Called-up share capital

30.09.2021
£
Allotted, called-up and fully-paid
1 Ordinary share of £ 1.00 1

Upon incorporation, one Ordinary share was issued at par.